Maintaining strategic connections with the research community, industry and government.
The Compounds Australia Strategic Advisory Board (SAB) aims to meet 2 times a year and will provide a mechanism to capture and deliver strategic advice to the Director of the Griffith Institute for Drug Discovery (GRIDD) on the advancement of Compounds Australia’s vision, mission and objectives. The Advisory Board will play a key role in:
- Providing strategic advice to the GRIDD Director on the facility’s strategic plan, funding model and risk management;
- Securing strategic stakeholder support for Compounds Australia;
- Developing and maintaining strategic connections with the research community, industry and government.
The SAB will not have an operational focus or be responsible for operational decisions.
Advisory board members
Mr Mario Pennisi AM (Chair) - Company Director, Strategist
Associate Professor Yun Feng - Academic Lead, Compounds Australia, GRIDD, Griffith University
Associate Professor Rohan Davis - Academic Lead, Naturebank, GRIDD, Griffith University
Professor Mike Jennings - Deputy Director, Institute for Glycomics, Griffith University
Professor Vicky Avery - Principal Research Leader, Discovery Biology, GRIDD, Griffith University
Professor Guillaume Lessene - Laboratory Head; Leader, New Medicines and Advanced Technologies Theme, Walter and Eliza Hall Institute
Dr Lavinia Proctor - Director, Accelerait RDI
Professor Jonathan Baell - Director, Australian Translational Medicinal Chemistry Facility, Monash University
Dr Jack Ryan - Research Director, CSIRO Biomedical Manufacturing Program, CSIRO
Dr Mark Blaskovich - Director, Centre for Superbug Solutions, Institute for Molecular Bioscience, University of Queensland
Professor Michelle Burford - Dean, Research Infrastructure, Griffith University